Valeant to Buy Obagi Medical
Wednesday, March 20, 2013Canadian drugmaker Valeant Pharmaceuticals International Inc. today said it would buy Long Beach's Obagi Medical Products Inc. for about $344 million to boost its dermatology business, Reuters reports. Obagi makes physician-prescribed skin-care products.
>>